Celltrion Pharm

068760.KQ

51.95 USD

-0.29

-0.56%

Overview

Last close

51.95 usd

Market cap

2.26B usd

52 week high

52.24 usd

52 week low

30.18 usd

Target price

94.05 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

12.1245

Price/Book Value

7.4999

Enterprise Value

2.24B usd

EV/Revenue

6.2716

EV/EBITDA

42.8969

Key financials

Revenue TTM

189.99M usd

Gross Profit TTM

55.91M usd

EBITDA TTM

29.60M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

532.45M usd

Net debt

86.52M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.